Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
18.71
0.00 (0.00%)
At close: Nov 21, 2025, 4:00 PM EST
18.72
+0.01 (0.06%)
After-hours: Nov 21, 2025, 7:00 PM EST
Evommune Market Cap
Evommune has a market cap or net worth of $562.75 million as of November 21, 2025.
Market Cap
562.75M
Enterprise Value
476.73M
1-Year Change
n/a
Ranking
Category
Stock Price
18.71
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $562.75M, an increase of 16.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 562.75M | -3.01% |
| Nov 19, 2025 | 580.20M | -4.46% |
| Nov 18, 2025 | 607.27M | 3.80% |
| Nov 17, 2025 | 585.01M | 6.28% |
| Nov 14, 2025 | 550.42M | 0.44% |
| Nov 13, 2025 | 548.01M | -6.66% |
| Nov 12, 2025 | 587.11M | 0.26% |
| Nov 11, 2025 | 585.61M | 0.78% |
| Nov 10, 2025 | 581.10M | 4.94% |
| Nov 7, 2025 | 553.73M | 15.06% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 939.79B |
| Johnson & Johnson | 487.91B |
| AbbVie | 411.64B |
| UnitedHealth Group | 279.99B |
| AstraZeneca | 275.69B |
| Novartis AG | 243.58B |
| Merck & Co. | 235.92B |
| Abbott Laboratories | 219.36B |